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Summary.-The natural history of 45 cases of smouldering leukaemia has been
studied. Males and females were equally represented, with a median age of 60-5.
The median survival of the whole group was only 20 months, but rare cases lived
10 years or longer. 38% developed acute leukaemia; the remainder usually died of
the results of marrow failure. Although it was possible to divide these marrow dys-
plasias morphologically into 3 major subgroups (refractory anaemia with excess
of myeloblasts, chronic myelomonocytic leukaemia and chronic erythraemic mye-
losis), several displayed transitional features. Many showed refractory macrocytosis
at diagnosis. The survival of the 3 groups was similar, though patients with high
monocyte counts tended to present with less anaemia and fared rather better than the
others. Statistical analysis suggests that increasing age, severe anaemia, thrombo-
cytopenia and hepatomegaly are associated with a poor prognosis. Chemotherapy,
when attempted, was usually unsuccessful.
THE TERM smouldering ("oligoblastic")
leukaemia was introduced by Rheingold
et al. (1963) to distinguish a group of
patients, usually presenting with single or
multiple cytopenias, whose marrows, while
showing some of the maturation defects
of acute myeloblastic or myelomonocytic
leukaemia, differ from these in having a
lower proportion of marrow blast cells.
Clinically, the condition is more indolent
than acute leukaemia, and particularly
affects older individuals. A number of
descriptive morphological terms have been
applied to this syndrome, of which refrac-
tory anaemia with excess of myeloblasts
(RAEM) (Dreyfus et al., 1970), chronic
myelomonocytic leukaemia (CMML)
(Miescher & Farquet, 1974; Geary et al.,
1975), chronic erythraemic myelosis (CEM)
(Kass & Schnitzer, 1975) and, less com-
monly, chronic erythromonocytic leukae-
tnia (Broun, 1969) are among those used.
However, it has been quiestioned whether
subdivision into such categories is valid,
and whether thev have any clinical
relevance.
In this study, 45 cases of smouldering
leukaemia investigated in a single clinic
have been followed for periods of up to
14 years, in an attempt to identify clinical
and/or haematological features of possible
prognostic significance. We also attempted
to assess the validity of classifying our
cases into 3 of the morphological types
mentioned above.
MATERIALS AND) METHODS
WN'e attempted to collect the records of all
patients with a diagnosis of smouldering or
subacute" myeloblastic leukaemia seen in
the Universitv Department ofClinical Haem-
atology at Manchester Royal Infirmary
between 1971 and 1976. Since these titles are
not yet included in the International Classi-
fication ofDiseases, a fewr cases may have been
included under other categories and thus
overlooked. Eventually, 47 cases were identi-
fied, of which one was initially referred in
1962 and subsequently reclassified as a case
of smouldering leukaemia. Two were dis-
carded because ofinadequate documentation.
During this time., 480 cases of myeloblastic
leukaemia (AML) and its morphologicalSAMOUILDERING LEUKAEiMIA
variants were investigated and treated in the
Department. An arbitrary level >500 blasts
in the marrow was chosen as identifving
smouldering leukaemia. This figure is usuall,
cited in the literature as discriminating
leukaemic from dysmyelopoietic disoirders.
which may not necessarily be leukaemic. The
upper limit waxs chosen as 40%0, below which
a diagnosis of smouldering leukaemia is
tenable, in accordance with tlhe FAB classifi-
cation (Bennett, et al., 1976). In the blood.
the following parameters were assessed:
degree of anaemia. neutropenia, monocytosis
and thrombocytopenia, and the presence of
myeloblasts or nucleated red cells. In addi-
tion to the proportion of blast cells, the
following morphological features were evalu-
ated in the marrow: degree of monocytosis.
number of megakaryocytes and their mor-
phology, and the degree of dyserythropoiesis,
with particular reference to the proportion
of multinucleated erythroid precursors. and
to the type and number of sideroblasts, as
described by Mollin (1965) and Hast (1978).
Marrow smears were stained with Prussian
blue for the demonstration of non-haem iron
in the ervthroblasts. "Ringed" sideroblasts
were defined as erythroblasts with large
siderotic granules arranged in a perinuclear
ring or collar, covering at least one-third of
the circumference of the nucleus. "Inter-
mediate" sideroblasts were defined as normo-
blasts with more than 6 non-haem iron
granules, but diffusely scattered in the cyto-
plasm. Only patients with a predominance
of "rings" (i.e. >5000 of the total number of
sideroblasts) were included in the ringed
sideroblast group. The "intermediate" group
consisted of the remaining patients. with
mainly intermediate sideroblasts.
On the basis of these morphological feat-
ures, in blood and marrow, the patients were
allocated to one of the 3 main types of
oligoblastic leukaemia: RAEM, CMAIL and
CEM. fn some cases, marrow cultures for
CFU-C. CFU-E and cytogenetic analysis
-were undertaken. The prognostic value of
these has already been reported (Milner
etal., 1977).
Clinically, information was sought about
age, sex. length of history at diagnosis.
evidence of exposure to potential marrow
toxins. physical signs at diagnosis. subse-
quent clinical course, and survival. WAhen
patients died at home. or at another hospital.
an attempt w-%as made to ascertain tfhe mode
of death from information obtained from the
patient's familv doctor or consultant
physician.
Statistical methods
Details for each patient wA-ere put on to
coding forms and. after input, to computer.
were analvsed in two wXavys:
(1) The effect of each variable (age, sex.
W;VBC, etc.) was analysed individually by
calculating Kaplan-Meier survival curves.
which were then compared using the log-
rank test (Peto et al., 1977). For con-
uous variables, a convenient number of
categories was first of all defined, and a
log-rank P value for trend calculated.
(2) The Cox regression method was used to
detect prognostic variables. This multi-
variate analysis has the advantage that
the merit of each variable at each stage is
assessed. whilst correcting for the effects
of any other variables in the analysis. If
hazard function A(t) is the chance of
dying in month t in the patients alive at
the beginning of the month. we assume
A(t) =eaAO(t)
where Ao(t) is a standard hazard function
and a=zlil +Z2/2 +. +Zppp where
the z's are a set of p prognostic variables
and the f's are coefficients estimated by
a maximum-likelihood iterative proced-
ure. A stepwise procedure wNas adopted.
First, the most important single predictor
was found, and the next variable to be
added to the analysis was the one which
most improved the log-likelihood. More
variables were added until none of them
could significantly improve the log-
likelihood.
RESULTS
The age range ofthe patients was 44-77
years, with a median of 60'5. Males and
females were almost equally represented.
The presenting signs and symptoms are
shown in Table I. The most frequently
encountered symptoms were those attribu-
table to chronic anaemia, but 24% also
had a history of unusual bruising or
bleeding. Recurrent infections were rare,
but 2 patients had a history of oral ulcera-
tion. Toxic symptoms such as fever.
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TABLE I. The presenting clinical features
in 45 cases of smrouldering leukaemia
No. 0
23 51
.).) 49)
Females
Mfales
Symptoms ofanaemia
Bruising
Splenomegaly
Hepatomegaly
40
1 1
:3
9
89
24
7
20
sweats, anorexia, bone pain or rashes,
commonly seen in acute leukaemia, were
rare. Hepatomegaly occurred in 9 patients,
and 3 had palpable spleens. No patient
had gum hypertrophv.
Haematologicalfindinys
A resume ofthe haematological features
at the time of diagnosis is shown in
Table II. There was a wide range in the
total white-cell count, but most; were low,
with a median of 4 0 x 109/I. Most, of the
patients were anaemic, with a median
haemoglobin value of 8 8 g/dl. The plate-
let counts ranged from <10 x 109/1 to
324 x 109/1, with a median of 61 x 109/1.
The peripheral-blood films showed a
variety of red-cell changes: most patients
(27/45) had moderate macrocytosis, but
a few showed some microcytic hypochro-
mic cells. Nucleated red cells were seen in
7 patients, including 2 of those classified
as CEM. Granulocytes often showed
defective granulation, and rarely Dohle
bodies; 20 cases showed the pseudo-Pelger
anomaly. Absolute monocytosis (>0 8 x
109/1) was seen in 9 cases. Occasional blast
cells were present in the peripheral blood
of 14 patients.
TABLE II. Peripheral-blood findings
at presentation
Low Hb (< I1 g/(ll)
LowWVBC (<4x109/1)
High WBC (>11 x 109/1)
Thrombocytopenia
Absolute monocytosis (> 0.8 x 109/1)
Giant platelets
Granulocyte abnormality*
Blasts
Macrocytosis
No. 0
'36 80
23 51
6 13
34 76
9 20
7 16
30 67
14 31
27 60
* e.g., pseu(lo-Pelger/agranular neutrophils.
TABLE III. -arrow morphology at
presentation
No.
35
6
4
Hyperplasia
Hypoplasia
Normoceellular
Erythroid byperplasia
(A:E ratio < 2:I1)
Blasts
5-20%
20 400,/o
Sideroblastie
Intermeidate
Ring
Micromegakaryocytes
,'o
78
14
9
11 25
42 93
3 7
I1
:3
:3
25
7
11
Marrow. This was examined in all
cases (Table III). Of the 45 cases, 35 were
allocated by two separate observers to a
subcategory of RAEM, 6 to CMML and
4 to CEM. Of the patients with blast
counts > 20%, 2 died of acute leukaemia
at 5 and 23 months. Only 2 cases showed
Auer rods in the blast cells, while 5 cases
showed > 10% micromegakaryocytes in
the marrow. The type of pathological
sideroblast seen in our cases was of
interest. Fourteen cases showed patho-
logical sideroblasts, but only 3 showed
> 5000 true ring sideroblasts; the remain-
der, though exhibiting intermediatesidero-
blasts, mainly in later erythroblasts,
showed no gross mitochondrial iron over-
load.
Clinical course
Four patients had a history of exposure
to therapeutic irradiation for malignant,
MONTrHS,
FIG. 1.- Survival curve for 45 patients
withi oligoblastie leukaemia (0, survivors).
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TABLE IV
All patients
Sex
M
F
Age (years)
<64
>64
Symptoms ofanaemia
Yes
No
Bruising
Yes
No
Hepatomegaly
Yes
No
Splenomegaly
Yes
No
1.-Patient survival times (in months)*
No. ofpatients Range Median survival
43 1-168 17
22 3-168
21 1-100
22 3-168
21 1-59
38 1-168
5 5-48
12 1-168
31 3-100
9 3-48
34 1-168
3 4-23
40 1-168
Hb
Normal 7 3-48
Low 36 1-168
WBC
Normal 15 3-58
Low 22 1-168
High 6 3-54
Platelets
Normal 11 5-100
Low 32 1-168
Monocytosis
Yes 8 3-58
No 35 1-168
Blasts in peripheral blood
Yes 13 3-48
No 30 1-168
Marrow cellularity
Normal 4 8-168
Hypo 6 1-40
Hyper 33 3-100
Marrow blasts
5-20% 40 1-168
20-40% 3 1-24
RAEM 34 1-168
CMML 6}9 3-5} 3-100 CEMM 3} 10100}
10
Transfusion
Yes 32 3-100
No 11 1-168
Cytotoxic drugs
Yes 11 5-48
No 32 1-168
* Excluding 2 patients withdrawn alive at 28 and 120 months.
17
14
20
12
13
34
22
12
8
18
5
17
34
12
21
13
27
22
13
32
14
12
20
41
9
17
17
9
16
27l22
22
17
12
21
16
disease. One had taken phenylbutazone
for a long time. Survival from diagnosis
ranged from 1 month to 14 years. (The
patient surviving only 1 month did not die
of acute leukaemia.) Two patients are
still alive 2 and 10 years from diagnosis
(Fig. 1). It was possible to ascertain the
cause of death in 43 patients. Seventeen
were known to have evolved into a picture
identical with acute myeloblastic ormyelo-
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monocytic leukaemia by the time of
death. The remainder died either of
incidental causes (9) or as a result of
marrow failure (i.e. haemorrhage or infec-
tion). The mean survival from diagnosis
was 23 5 months, with a median of 20
months.
Statistical analysis
Table IV shows the median and range
of the survival times in months for all
patients, and for patients separated into
possible prognostic groups. Although the
exact ages were known, the patients have
been divided simply into those below and
above the median age.Two patients known
to be alive at 28 months and 120 months
respectively have been excluded from this
breakdown.
The survival times of these prognostic
groups were compared by the actuarial
life-table method of Kaplan and Meier,
and by the log-rank test, for which the 2
patients still alive were included. Since it
was difficult to distinguish deaths which
were an indirect result of the disease and
those from other causes, no attempt has
been made to correct for intercurrent
(leaths.
On examination ofthe survival curves
age, hepatomegaly, haemoglobin, platelets
and blood monocytosis showed slight
differences in survival, though none of
these was statistically significant, pos-
TABLE V. Results of Cox regression
\Variable(
Step I
Age
Step 2
Age
Hb*
'Step 3
Age
Hb
Cytotoxic clrugst
* Normal= 1, low = 2.
t No=l,yes=2.
0 (0:36 0(05
0 045
0 993()
0 051
1* 006
0 520
0 (025
NS
sibly due to the small numbers in some of
the groups. Factors which indicated a
poorer prognosis in this one-dimensional
analysis were age over 64, hepatomegaly,
low haemoglobin, low platelet count and
absence of monocytosis. As an example,
the survival curves for different haemo-
globin levels are shown in Fig. 2. One
interesting correlate was the association
of monocytosis with higher haemoglobin.
Table V shows the results of the Cox
regression. The actual age, rather than the
grouped age, was used for this analysis,
and this was the most important predictor.
After age, haemoglobin significantly im-
proved the log-likelihood. A "low", as
opposed to "normal", haemoglobin
increased the hazard and significantly
reduced the survival. Although the use of
cytotoxic drugs was the next important
variable, its effect was not statistically
significant.
I)ISCUSSION
The incidence of smouldering leukaemia
ill our clinic (abouit 10% of all cases of
myeloblastic leukaemia) is similar to that
reported by Dreyfus (1976).
The definition of smouldering ("oligo-
blastic", subacute myeloblastic) leuk-
aemia is based on marrow morphology
and clinical presentation. The latter pic-
ture is characterized by signs of incipient
1;0 lr70 180 marrow failure rather than by the toxic,
metabolic and extramedullary features
patients wvith which often dominate the picture of acute
(t
-) com- leukaemia. Nevertheless, a proportion of an theliaemo c
ID, survivors), cases of smouldering leukaemia, do eventui
0 :30 60 90
NIONTHS
FIG. 2.-Survival cturves for :36
liaemoglobin values <10 g/d:
pared with 9 patients in wlhor
globin was > 1 0 g/!d ( ) ( 4
164
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ally evolve into AML, though the fre-
quency with which this occurs differs
widely in published series. Some authori-
ties regard smouldering leukaemia as one
variant of the preleukaemic syndrome
(Kass, 1979) of which marrow dysplasia
is often the hallmark. As Heimpel (1979)
has emphasized, in a severely dysplastic
marrow the precise enumeration of blast
cells against a background of atypical
monocytes is difficult. Our studies show
that, although some cases of smouldering
leukaemia have an extremely chronic
course, the diagnosis is a grave one, with
median survival only 20 months. Evolu-
tion into acute leukaemia may occur at
any time after the initial diagnosis; 17 of
our original 45 cases (38%o) are known to
have so evolved. However, many patients
died within 2 years, of causes often related
to marrow insufficiency, and were in a
sense not long-term candidates for such
evolution. Of our 45 cases, 4 had trans-
formed within 6 months into acute
leukaemia. These included I of the 3
cases found at initial diagnosis to have
> 20% marrow blasts. It is of interest
that some patients with > 10% blasts in
the marrow have long survivals; in one
case, 1 0 years.
Although the separationi of the variotus
types of smouldering leukaemia into 3 or
more subtypes on morphological grounds
is frequently accepted, some have ques-
tionied its practical validity (Lichtman,
1979). Our studies confirm this view;
although it was possible to divide ouir
material suibjectively into 3 major mor-
phological groups, some cases showed
overlapping features.
It seems appropriate toregard smoulder-
ing leukaemia as a continuous morpho-
logical spectrum with a number of
distinctive landmarks; our 3 groups had
comparable survival times, though the
patients labelled as CMML seemed to fare
rather better than those categorized as
RAEM. We agree with Dohy et al. (1980)
that refractory macrocytosis is a frequent
finding in pre-leukaemic marrow dys-
plasia, and should be accorded the same
significance as an unexplained neutropenia
or thrombocytopenia.
In the blood picture, the main features
determining prognosis were anaemia and
thrombocytopenia at diagnosis. The total
WBC did not appear to influence the out-
come, but patients with higher monocyte
counts did a littler better than the others.
Since a high peripheral monocyte count
is one of the features determining a
diagnosis of CMML, this may be relevant
to the marginally longer survival of this
group. These patients also tended to
higher haemoglobin levels, which may be
significant in the light of the reported
role of cells of the monocyte/macrophage
series in promoting haemopoiesis (Rine-
hart et al., 1978). It is also possible that a
patient with an absolute monocytosis is
able to compensate for chronic neutro-
penia.
Another interesting point concerns the
degree and type of sideroblast seen in
these patients. We agree with Hast &
Reizenstein (1981) that a predominance
of "true" ring sideroblasts is rare in pre-
leukaemia and smouldering leukaemia,
even when there is gross dyserythropoiesis.
Intermediate or incomplete rings of the
type described above, are, however, com-
mon (24% in ouir series). Thus the picture
characteristic of idiopathic refractory
sideroblastic anaemia (viz. gross mito-
chondrial iron overload affecting most of
both early and late normoblasts (Mollin,
1965; Hall & Losowsky, 1966)) is rare in
preleukaemia. Recent work suggests that
these morphological differences are reflec-
ted by distinctive ferrokinetic patterns
in the two syndromes (Cazzola et al.,
1982). Apart, from anaemia, the only
distinctive clinical feature apparently sig-
nificant in predicting survival was hepato-
megaly, which was present in 9/43 cases
entered into the statistical analysis. By
contrast, only 3 cases had palpable spleens
at diagnosis, and so we were unable to
decide whether splenomegaly alone was
of prognostic significance. Cohen et al.
(1979), however, found that combined
hepato- and splenomegaly in a patient
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with "subacute" leukaemia was a sinister
feature, especially if associated with a
high WBC count.
Our experience with chemotherapy in
this syndrome have been disappointing
as is reflected in the statistical analysis of
survival. Five patients were treated dur-
ing the "chronic" phase with cytotoxic
drugs (usually cytosine arabinoside and
thioguanine) but only 1 showed any
improvement, with temporary disappear-
ance of blast cells in the marrow; others
simply became more cytopenic without
clinical improvement. Experience with
chemotherapy during the acute "blastic"
phase was universally disappointing, and
Freireich (1979) has recently, identified a
previous history ofsmouldering leukaemia
as a bad prognostic characteristic in pre-
dicting effects ofchemotherapy in AML.
These studies suggest that combined
analysis of morphological and clinical
features, together with cytogenetic and
marrow cultures, which have previously
been reported on our own cases (Milner
et al., 1977) and in other series, may permit
a reasonably accurate prognosis at diag-
nosis in a new case of smouldering leuk-
aemia.
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